Showing results (331-340 of 909) with videos related to

Sort By:
Pageof 91
European Heart Journal|February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definitionFaiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
ESC Heart Failure|January 26, 2018
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney diseaseBertram Pitt, David A Bushinsky, Dalane W Kitzman, et al.
The American Journal of Medicine|April 2, 2013
Systolic blood pressure and cardiovascular outcomes during treatment of hypertensionMichael A Weber, George L Bakris, Allen Hester, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 24, 2021
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trialPieter Martens, João Pedro Ferreira, John Vincent, et al.
European Journal of Heart Failure|April 21, 2025
Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction according to body weightJawad H Butt, Scott D Solomon, Muthiah Vaduganathan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rateKen Lee Chin, Timothy Collier, Stuart Pocock, et al.
JAMA|July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical TrialGeorge L Bakris, Bertram Pitt, Matthew R Weir, et al.
The New England Journal of Medicine|November 22, 2014
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitorsMatthew R Weir, George L Bakris, David A Bushinsky, et al.
Circulation|November 17, 2020
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, Stefan D Anker, Rajiv Agarwal, et al.
The New England Journal of Medicine|December 2, 2020
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesGeorge L Bakris, Rajiv Agarwal, Stefan D Anker, et al.
Pageof 91